
|Articles|December 7, 2020
Signant Health Acquires VirTrial
Advertisement
Signant Health has announced the acquisition of VirTrial, a provider of software solutions for remote site startup and decentralized clinical trial conduct.
In addition to VirTrial's tele-research platform, which includes secure video, audio, chat, and connected medical device capabilities for decentralized patient-site interaction and assessments, the agreement provides Signant with a solution to address remote site startup and monitoring. Known as Virtual Site Monitoring, the solution leverages wearable technology for in-house or outsourced clinical research associates to remotely conduct site evaluation, initiation, and monitoring visits.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Workforce Compression in AI-Driven Clinical Trial Operations
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting
4
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
5



